| Name | Theralizumab |
|---|
| Description | Theralizumab (TGN1412) is a superagonist anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can be used for the research of rheumatoid arthritis[1][2]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |